[go: up one dir, main page]

IL136962A0 - Combination therapy for the treatment of migraine - Google Patents

Combination therapy for the treatment of migraine

Info

Publication number
IL136962A0
IL136962A0 IL13696200A IL13696200A IL136962A0 IL 136962 A0 IL136962 A0 IL 136962A0 IL 13696200 A IL13696200 A IL 13696200A IL 13696200 A IL13696200 A IL 13696200A IL 136962 A0 IL136962 A0 IL 136962A0
Authority
IL
Israel
Prior art keywords
migraine
treatment
combination therapy
therapy
combination
Prior art date
Application number
IL13696200A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL136962A0 publication Critical patent/IL136962A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13696200A 1999-06-30 2000-06-22 Combination therapy for the treatment of migraine IL136962A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14168099P 1999-06-30 1999-06-30

Publications (1)

Publication Number Publication Date
IL136962A0 true IL136962A0 (en) 2001-06-14

Family

ID=22496730

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13696200A IL136962A0 (en) 1999-06-30 2000-06-22 Combination therapy for the treatment of migraine

Country Status (11)

Country Link
US (1) US20030216458A1 (es)
EP (1) EP1064948A3 (es)
JP (1) JP2001031568A (es)
KR (1) KR20010066886A (es)
AU (1) AU4271100A (es)
CA (1) CA2312633A1 (es)
CO (1) CO5190678A1 (es)
HU (1) HUP0002508A3 (es)
IL (1) IL136962A0 (es)
PE (1) PE20010513A1 (es)
ZA (1) ZA200003235B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US20020077328A1 (en) * 2000-07-13 2002-06-20 Fred Hassan Selective cyclooxygenase-2 inhibitors and vasomodulator compounds for generalized pain and headache pain
WO2002017896A2 (en) * 2000-08-29 2002-03-07 Peter Van Patten Combination for the treatment of migraine comprising a cyclooxygenase-2 inhibitor and acetylsalicylic acid
MXPA05006954A (es) 2002-12-26 2005-09-22 Pozen Inc Formas de dosificacion de capas multiples que contienen nsaids y triptanos.
NL2000351C2 (nl) 2005-12-22 2007-09-11 Pfizer Prod Inc Estrogeen-modulatoren.
AU2009260166B2 (en) 2008-06-20 2014-10-09 Alphapharm Pty Ltd Pharmaceutical formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
US5872145A (en) * 1996-08-16 1999-02-16 Pozen, Inc. Formulation of 5-HT agonist and NSAID for treatment of migraine
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
CN1145486C (zh) * 1997-07-03 2004-04-14 美国辉瑞有限公司 含eletriptan半硫酸盐和咖啡因的药用组合物

Also Published As

Publication number Publication date
AU4271100A (en) 2001-01-04
KR20010066886A (ko) 2001-07-11
CA2312633A1 (en) 2000-12-30
EP1064948A3 (en) 2003-01-08
EP1064948A2 (en) 2001-01-03
CO5190678A1 (es) 2002-08-29
ZA200003235B (en) 2002-01-02
PE20010513A1 (es) 2001-04-21
JP2001031568A (ja) 2001-02-06
HUP0002508A3 (en) 2001-07-30
US20030216458A1 (en) 2003-11-20
HUP0002508A2 (hu) 2001-05-28
HU0002508D0 (en) 2000-08-28

Similar Documents

Publication Publication Date Title
IL164599A0 (en) Combination therapy for the treatment of cancer
AU2002350235A1 (en) Combination bacteriolytic therapy for the treatment of tumors
IL158329A0 (en) Antiangiogenic combination therapy for the treatment of cancer
EP1077704A4 (en) COMBINATION THERAPY FOR TREATING DEPRESSION
HUP0500424A2 (en) Combination therapy for the treatment of cancer
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
IL146697A0 (en) SELECTIVE iGluR5 RECEPTOR FOR THE TREATMENT OF MIGRAINE
IL136960A0 (en) Combination therapy for the treatment of migraine
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
ZA200110436B (en) Therapeutic use of melatonin.
AU2001285156A1 (en) Combination therapy for the treatment of migraine
IL136962A0 (en) Combination therapy for the treatment of migraine
IL136025A0 (en) Combination therapy for the treatment of migraine
IL136024A0 (en) Combination therapy for the treatment of migraine
HUP0100365A3 (en) Combination therapy for the treatment of aids
GB2363604B (en) S-nitrosothiols as agents for the treatment of circulatory dsyfunctions
SI1451177T1 (sl) Substituirani 2-pirolidin-2-il-1H-indolni derivati za zdravljenje migrene
GB9904252D0 (en) Composition for the treatment of pain
GB9807938D0 (en) Combination therapy for the treatment of AIDS
GB9819590D0 (en) Combination therapy for the treatment of aids
KR100511819B1 (en) Compositions and Methods for the Treatment of Tumor
GB9901505D0 (en) Therapeutic treatment
GB9924980D0 (en) Therapeutic treatment
ZA9810306B (en) Combination therapy for the treatment of aids
KR100512820B1 (en) Compositions and Methods for the Treatment of Tumor